Search Results 291-300 of 17276 for SC

  1. Roberto P. Benzo, M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

    Fellow - Pulmonary and Critical Care MedicineMedical University of South Carolina. 1996. Resident - Internal MedicineMedical University of South Carolina. 1995.

  2. Publications - Ali J. Ainsworth, M.D. - Mayo Clinic

    Baumgarten SC, Chen V, Ogle AJ, Fought AJ, Li Y, Ainsworth AJ. Effect of music on anxiety during intrauterine insemination: a randomized controlled trial ...

  3. Syphilis - Symptoms and causes - Mayo Clinic

    Syphilis is an infection caused by bacteria. Most often, it spreads through sexual contact. The disease starts as a sore that's often painless and typically ...

  4. Publications - Ryan W. Stidham, M.D. - Mayo Clinic

    2024 Nov 04; 30(11):2181-2190. View PubMed; Enchakalody BE, Wasnik AP, Al-Hawary MM, Wang SC, Su GL, Ross B, Stidham RW. Local Assessment and Small Bowel ...

  5. Gastroparesis - Doctors and departments - Mayo Clinic

    Camilleri, Michael M.D., D.Sc. Minnesota. Cangemi, David J. M.D.. Florida. Farrugia, Gianrico M.D.. Minnesota. Fox, Jean C. M.D.. Minnesota. Grover, Madhusudan ...

  6. Degarelix (subcutaneous route) - Side effects & uses - Mayo Clinic

    Degarelix is a type of medicine called a gonadotropin-releasing hormone (GnRH) antagonist. It helps treat prostate cancer by lowering the amount of testosterone ...

  7. Study To Assess Batoclimab In Participants With Active Thyroid Eye Disease - Mayo Clinic

    The purpose of this study is to evaluate the efficacy of batoclimab 680 milligrams (mg) subcutaneous (SC) once a week (QW) for 12 weeks followed by 340 mg SC QW ...

  8. Hyperthyroidism - Symptoms and causes - Mayo Clinic

    Hyperthyroidism happens when the thyroid gland makes too much thyroid hormone. This condition also is called overactive thyroid. Hyperthyroidism speeds up the ...

  9. Publications - Yajue Huang, M.D., Ph.D. - Mayo Clinic

    ... SC, Stathias V, Chen XS, Barcellos-Hoff MH, Starr TK, Winterhoff BJ, Nelson AC, Mok SC, Kaufmann SH, Drescher C, Cieslik M, Wang P, Birrer MJ, Paulovich AG.

  10. A Study To Evaluate Efficacy Of Remibrutinib Compared To Dupilumab At Early Timepoints In Adults With Chronic Spontaneous Urticaria Inadequately Controlled By Second Generation H1-antihistamines - Mayo Clinic

    ... (s.c.) followed by 300 mg every 2 weeks s.c.) at early timepoints (4 weeks and earlier), when administered as an add-on treatment to second generation H1 ...